YANKCOM Partnership Buys Shares of 1,034 Danaher Co. (NYSE:DHR)

YANKCOM Partnership bought a new stake in shares of Danaher Co. (NYSE:DHR) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 1,034 shares of the conglomerate’s stock, valued at approximately $237,000.

A number of other hedge funds have also added to or reduced their stakes in DHR. FMR LLC lifted its position in Danaher by 15.8% in the 3rd quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock worth $6,566,116,000 after buying an additional 3,217,631 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its position in Danaher by 17.6% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate’s stock worth $996,141,000 after buying an additional 535,254 shares during the last quarter. International Assets Investment Management LLC lifted its position in Danaher by 40,196.5% in the 3rd quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate’s stock worth $119,539,000 after buying an additional 428,897 shares during the last quarter. Montrusco Bolton Investments Inc. lifted its position in Danaher by 30.4% in the 3rd quarter. Montrusco Bolton Investments Inc. now owns 1,705,884 shares of the conglomerate’s stock worth $465,617,000 after buying an additional 397,671 shares during the last quarter. Finally, Union Bancaire Privee UBP SA bought a new stake in Danaher in the 4th quarter worth approximately $74,551,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on DHR. TD Cowen boosted their target price on Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Guggenheim started coverage on Danaher in a research note on Thursday, December 19th. They issued a “buy” rating and a $275.00 price target on the stock. StockNews.com cut Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. Citigroup decreased their price target on Danaher from $285.00 to $265.00 and set a “buy” rating on the stock in a research note on Thursday, January 30th. Finally, Bank of America raised Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price target on the stock in a research note on Friday, December 13th. Seven investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $278.00.

Danaher Price Performance

Shares of DHR stock opened at $209.95 on Friday. The stock has a market cap of $151.64 billion, a price-to-earnings ratio of 39.76, a PEG ratio of 2.80 and a beta of 0.83. The business’s fifty day moving average is $233.96 and its 200 day moving average is $252.39. Danaher Co. has a twelve month low of $209.10 and a twelve month high of $281.70. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the business earned $2.09 EPS. Research analysts expect that Danaher Co. will post 7.77 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were issued a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 0.51%. The ex-dividend date of this dividend was Friday, December 27th. Danaher’s dividend payout ratio (DPR) is 20.45%.

Insider Activity

In other news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.